{"id":38818,"date":"2020-08-28T07:32:58","date_gmt":"2020-08-28T07:32:58","guid":{"rendered":"https:\/\/i-base.info\/htb\/?p=38818"},"modified":"2020-08-28T09:15:09","modified_gmt":"2020-08-28T09:15:09","slug":"ema-supports-use-of-dapivirine-vaginal-ring-to-prevent-hiv-in-high-incidence-countries","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/38818","title":{"rendered":"EMA supports use of dapivirine vaginal ring to prevent HIV in high-incidence countries"},"content":{"rendered":"<div>\n<p class=\"HTBsubhead2articletitle\"><b><span lang=\"EN-US\">Simon Collins, HIV i-Base<\/span><\/b><\/p>\n<\/div>\n<div>\n<p class=\"HTBBODYtext\"><strong>On 24 July 2020, the EMA adopted a positive opinion for the safety and efficacy of a dapivirine vaginal ring to be used to protect against HIV.<\/strong><\/p>\n<\/div>\n<div>\n<p class=\"HTBBODYtext\">This was only for use in high incidence countries though, rather than within the EU.<\/p>\n<\/div>\n<div>\n<p class=\"HTBBODYtext\">Efficacy data reported a 35% reduction in HIV rates compared to placebo but as with other prevention studies, higher protection was reported with good adherence.<\/p>\n<\/div>\n<div>\n<p class=\"HTBBODYtext\">The ring contains 25 mg of dapivirine and lasts for one month.<\/p>\n<\/div>\n<div>\n<p class=\"HTBreference-noindent\"><span lang=\"EN-US\">Reference<\/span><\/p>\n<\/div>\n<div>\n<p class=\"HTBreference-noindent\"><span lang=\"EN-US\">EMA. Vaginal ring to reduce the risk of HIV infection for women in non-EU countries with high disease burden. (24 July 2020).<br \/>\n<\/span><a href=\"https:\/\/www.ema.europa.eu\/en\/news\/vaginal-ring-reduce-risk-hiv-infection-women-non-eu-countries-high-disease-burden\">https:\/\/www.ema.europa.eu\/en\/news\/vaginal-ring-reduce-risk-hiv-infection-women-non-eu-countries-high-disease-burden<\/a><\/p>\n<p><em>This article was originally posted on 25 August 2020.<\/em><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Simon Collins, HIV i-Base On 24 July 2020, the EMA adopted a positive opinion for the safety and efficacy of a dapivirine vaginal ring to be used to protect against HIV. This was only for use in high incidence countries &hellip;<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[],"class_list":["post-38818","post","type-post","status-publish","format-standard","hentry","category-transmission-and-prevention"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/38818","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=38818"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/38818\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=38818"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=38818"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=38818"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}